Overview
Total raised
$13.6M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 31, 2014 | Cold Genesys Secures $13.57M Series A Financing | Cold Genesys, Inc., a Newport Beach, CA clinical-stage biopharmaceutical company developing oncolytic immunotherapies for cancer, secured $13.57m Series A financing from Ally Bridge Group. In conjunction with the transaction, David Nikodem,... |
| Cold Genesys gets $13.6M Series A for oncolytic virus to treat bladder cancer; recycles assets from defunct biotech | Cold Genesys, a sort of latter-day spinoff of the once-promising cancer vaccine maker Cell Genesys, has an engineered oncolytic virus that shows promise in treating a dangerous form of bladder cancer. The Newport Beach, California company j... |